DrStrange
4 of a Kind
I have seen a number of commercials for a new drug - Opdivo - that adds four months to the life expectancy of the typical end stage cancer patient with a narrow number of cancers. (from six months to ten months.) This struck me as an off thing to advertise on 'main stream" TV, so I got curious and did some digging.
Basic data (best I could figure doing a quick study):
* The drug has been tested for some lung and skin cancers but is in the process of testing for a far wider range of cancers.
* The median patient saw life expectancy rise from six months to ten months. No idea about quality of life.
* The daily cost of treatment is ~$1,000 per day or $300,000 over the ten month lifespan of the patient
* A more expensive course of treatment is being tested, costing ~$3,000 per day and maybe adding another month or two to life expectancy. This treatment will cost a bit more than a million dollars per person.
* Depending on how these expansive tests works out, the company will eventually sell $100,000,000,000 to $300,000,000,000 (100 to 300 billion dollars) worth of drugs per year to US cancer patients if everyone who could benefit from the drug gets it at full price.
* For perspective - The 2015 discretionary military spending cap is $521 billion.
* Total prescription drug spending in the USA in 2014 was $374 billion.
* 2014 spending on food stamps was $74 billion.
So now I know why the drug company is advertising - this could be the most "valuable" drug ever invented. Of course the tricky part is getting someone to pay for it. The easy answer is let the tax payers pay for it through Medicare/Medicaid. I can't see how that could possibly be fiscally sustainable but knowing how motivated / desperate the dying can be maybe it will prove hard to say no.
I am mindful that the free market price for a patented life saving drug is everything you own and everything you can borrow (and for sure everything the insurance company / taxpayer will pay.) But I am not so sure the free market solution is best in this case. Keep in mind this isn't curing anything and is not extending the productive life of the typical patient, it is taking an end stage cancer victim and stretching out the final months of their life.
Maybe we let people die a few months faster if they don't have a million bucks? That would seem to be a departure in practice.
Maybe we have the government step in and greatly reduce the price? Though I can't see how that is legal.
Maybe we raise taxes and/or borrow the money to pay the asking price? And then we go broke even faster.
Let's be clear. In 2015 the costs for Opdivo are going to be relatedly modest. But in short order these types of costs are going to be crushing and force us to make hard choices. For me, the easy answer is "let the patient die unless they have personal wealth to afford a million dollar drug". But the optics of a pleading grandmother and her family begging for help are going to be tough.
DrStrange
PS and in case the economics of this aren't clear - if we make insurance companies / medicare / Medicaid pay for this treatment then the cost of insurance is going to rise significantly. Insurance just spreads the risk, in the end we collectively pay the total costs.
Basic data (best I could figure doing a quick study):
* The drug has been tested for some lung and skin cancers but is in the process of testing for a far wider range of cancers.
* The median patient saw life expectancy rise from six months to ten months. No idea about quality of life.
* The daily cost of treatment is ~$1,000 per day or $300,000 over the ten month lifespan of the patient
* A more expensive course of treatment is being tested, costing ~$3,000 per day and maybe adding another month or two to life expectancy. This treatment will cost a bit more than a million dollars per person.
* Depending on how these expansive tests works out, the company will eventually sell $100,000,000,000 to $300,000,000,000 (100 to 300 billion dollars) worth of drugs per year to US cancer patients if everyone who could benefit from the drug gets it at full price.
* For perspective - The 2015 discretionary military spending cap is $521 billion.
* Total prescription drug spending in the USA in 2014 was $374 billion.
* 2014 spending on food stamps was $74 billion.
So now I know why the drug company is advertising - this could be the most "valuable" drug ever invented. Of course the tricky part is getting someone to pay for it. The easy answer is let the tax payers pay for it through Medicare/Medicaid. I can't see how that could possibly be fiscally sustainable but knowing how motivated / desperate the dying can be maybe it will prove hard to say no.
I am mindful that the free market price for a patented life saving drug is everything you own and everything you can borrow (and for sure everything the insurance company / taxpayer will pay.) But I am not so sure the free market solution is best in this case. Keep in mind this isn't curing anything and is not extending the productive life of the typical patient, it is taking an end stage cancer victim and stretching out the final months of their life.
Maybe we let people die a few months faster if they don't have a million bucks? That would seem to be a departure in practice.
Maybe we have the government step in and greatly reduce the price? Though I can't see how that is legal.
Maybe we raise taxes and/or borrow the money to pay the asking price? And then we go broke even faster.
Let's be clear. In 2015 the costs for Opdivo are going to be relatedly modest. But in short order these types of costs are going to be crushing and force us to make hard choices. For me, the easy answer is "let the patient die unless they have personal wealth to afford a million dollar drug". But the optics of a pleading grandmother and her family begging for help are going to be tough.
DrStrange
PS and in case the economics of this aren't clear - if we make insurance companies / medicare / Medicaid pay for this treatment then the cost of insurance is going to rise significantly. Insurance just spreads the risk, in the end we collectively pay the total costs.
Last edited: